Tag: Clevidipine

Over 25% of patients undergoing major non-cardiac surgery experience perioperative hypertension, significantly increasing the risk of adverse cardiovascular events. Determining **which drug is used to treat hypertension in surgery** is crucial for anesthesiologists to ensure patient safety and optimize outcomes.

With an extremely short initial phase half-life of just one minute, CLEVIPREX (clevidipine) offers rapid and precise blood pressure reduction for critically ill patients. This article explains what does CLEVIPREX do and how its unique pharmacological profile addresses severe hypertension in controlled clinical settings.